Selective agonism in somatostatin receptor signaling and regulation
- 14 May 2008
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 286 (1-2) , 35-39
- https://doi.org/10.1016/j.mce.2007.09.009
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A functional comparison of recombinant and native somatostatin sst2 receptor variants in epitheliaBritish Journal of Pharmacology, 2007
- GPCR functional selectivity has therapeutic impactTrends in Pharmacological Sciences, 2007
- β-Arrestin-biased ligands at seven-transmembrane receptorsTrends in Pharmacological Sciences, 2007
- The evasive nature of drug efficacy: implications for drug discoveryTrends in Pharmacological Sciences, 2007
- Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathwayThe EMBO Journal, 2006
- Receptor Signaling and Endocytosis Are Differentially Regulated by Somatostatin AnalogsMolecular Pharmacology, 2005
- Multiple Signaling States of G-Protein-Coupled ReceptorsPharmacological Reviews, 2005
- Critical Role of Src and SHP-2 in sst2 Somatostatin Receptor-mediated Activation of SHP-1 and Inhibition of Cell ProliferationMolecular Biology of the Cell, 2003
- β‐Arrestin is involved in the desensitization but not in the internalization of the somatostatin receptor 2A expressed in CHO cellsFEBS Letters, 2002
- Agonist‐Mediated Endocytosis of Rat Somatostatin Receptor Subtype 3 Involves β‐Arrestin and Clathrin Coated VesiclesJournal of Neuroendocrinology, 2001